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Proton transfer and hydrogen bonding in the
organic solid state: a combined XRD/XPS/ssNMR
study of 17 organic acid–base complexes†
Joanna S. Stevens,*a Stephen J. Byard,b Colin C. Seaton,a Ghazala Sadiq,a
Roger J. Daveya and Sven L. M. Schroeder*ac
The properties of nitrogen centres acting either as hydrogen-bond or Brønsted acceptors in solid molecular
acid–base complexes have been probed by N 1s X-ray photoelectron spectroscopy (XPS) as well as
15N solid-state nuclear magnetic resonance (ssNMR) spectroscopy and are interpreted with reference to
local crystallographic structure information provided by X-ray diffraction (XRD). We have previously shown
that the strong chemical shift of the N 1s binding energy associated with the protonation of nitrogen
centres unequivocally distinguishes protonated (salt) from hydrogen-bonded (co-crystal) nitrogen species.
This result is further supported by significant ssNMR shifts to low frequency, which occur with proton
transfer from the acid to the base component. Generally, only minor chemical shifts occur upon co-crystal
formation, unless a strong hydrogen bond is formed. CASTEP density functional theory (DFT) calculations
of 15N ssNMR isotropic chemical shifts correlate well with the experimental data, confirming that
computational predictions of H-bond strengths and associated ssNMR chemical shifts allow the
identification of salt and co-crystal structures (NMR crystallography). The excellent agreement between
the conclusions drawn by XPS and the combined CASTEP/ssNMR investigations opens up a reliable
avenue for local structure characterization in molecular systems even in the absence of crystal structure
information, for example for non-crystalline or amorphous matter. The range of 17 different systems
investigated in this study demonstrates the generic nature of this approach, which will be applicable to
many other molecular materials in organic, physical, and materials chemistry.
Introduction
The crystallization of solid state acid–base donor–acceptor
systems with more than one component is a commonly used
route to tailor the physical and chemical properties of solid
organic products and their formulations. For example, during
the development of active pharmaceutical ingredients (APIs),
the physicochemical properties of the pure API may be unsuitable
for a chosen drug delivery route. Combining with a Brønsted
donor or acceptor can result in intermolecular bonding, either by
forming an ionic (salt) or hydrogen-bonded (co-crystal1–3) complex
with superior properties,1–4 which may include solubility,5
bioavailability,5,6 chemical and physical stability,7,8 hygro-
scopicity,9 and mechanical properties.10,11
Single crystal X-ray diﬀraction (XRD) is most commonly used
for determining whether proton transfer or hydrogen bonding
takes place between acid and base components,3,5,12–18 often in
conjunction with an analysis of structural indicators such as
bond angles and bond lengths.3,12,16,19 However, the unequivocal
determination of hydrogen positions is not always straightforward,
particularly with systems exhibiting proton disorder, temperature-
dependent migration, or other unusual behaviour.18 Analysis by
XRD is also constrained by a requirement for suitable single crystals,
whichmay not be available when solid-state preparation techniques
such as milling are used to form materials with more than one
component.20,21 Where single crystal XRD fails other commonly
available laboratory techniques such as vibrational spectroscopies
can sometimes provide the required information.12,13 Often, how-
ever, the determination of hydrogen and proton positions has to rely
on more advanced techniques such as neutron diffraction,12,18,19as
demonstrated for, e.g., urea/phosphoric acid,17,22,23 4,40-bipyridyl/
benzene-1,2,4,5-tetracarboxylic acid,24 4-methylpyridine/penta-
chlorophenol,25 and benzoic acid.26,27
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Over the last decade, solid-state NMR (ssNMR) methods
combined with computational chemical shift analysis5,28,29
have been added to the inventory of techniques for the char-
acterisation of hydrogen bonding and Brønsted interactions in
the organic solid state. Studies have shown that H-bonding and
proton transfer in two-component systems can be distinguished
using 15N ssNMR,5,21,29–32 as for example shown for co-crystals
and salts of a cancer-treatment API5 and for theophylline (1,3-
dimethyl-7H-purine-2,6-dione) systems.21,28,30 Density functional
theory (DFT) can be applied to correlate 15N ssNMR parameters
with crystal structures. For example, calculations for the
co-crystal form of a pharmaceutical API correctly predicted
chemical shifts (to low frequency) relative to the free base on
formation of strong H-bonds, in agreement with experimental
data.5 Similarly, comparison of predicted 15N chemical shift
values for complexes of dabco (1,4-diazabicyclo[2.2.2]-octane) and
dicarboxylic acids with experimental data confirmed Brønsted
and H-bonding interactions in these systems.29
Recently, we reported that X-ray photoelectron spectroscopy
(XPS) also reliably detects proton transfer: a strong positive N 1s
binding energy shift occurs due to protonation and identifies
the formation of a salt.21,28,30,33 The information of this chemical
shift analysis is conceptually very similar to that used in the
ssNMR approach,28 opening up an avenue to mutual validation
of results obtained with either technique. The principle of a
large N 1s shift with protonation was applied to identify the
nature of meta-aminobenzoic acid polymorphs (non-ionic vs.
zwitterionic),34 and an O 1s shift to higher binding energy was
also observed for an oxygen proton acceptor with formation of a
H-bond on moving from the gas to condensed phase.35 Very
importantly, long-range order is not a pre-requisite for the
application of XPS and ssNMR; both techniques are also
applicable to systems for which single crystal XRD would be
unfeasible, for example when a suitable single crystal cannot be
obtained, or when non-crystalline or amorphous samples are
analysed.36
The feasibility of a combined ssNMR/XPS approach to local
structure characterization in the organic solid state was intro-
duced for theophylline co-crystal/salt systems,28 but to explore
it more systematically we report here the examination of the
nature of the intermolecular interactions between components
of 17 acid–base complexes (Table 1 and Fig. 1), comparing XPS
results with experimental and calculated 15N ssNMR data. As in
our previous XPS study,33 we incorporate several development
API substances alongside a range of non-development acid–base
complexes including theophylline, aminobenzoic, and isonicotin-
amide base components with different acid co-formers and thus
differing acid strength.
These systems cover a wide range of pKa diﬀerences (DpKa),
from 3.9 to +17.7, between the acceptor and donor functional
groups, which will allow us to examine correlations between
DpKa values and the chemical shifts observable by XPS and
ssNMR in a systematic manner. Of the 17 complexes, 6 (4 salts,
2 co-crystals) are within the range 0 o DpKa o 3 (Table 1), for
which it is generally unpredictable whether H-bonding or proton
transfer takes place.12,37
Experimental
Starting materials
All non-development starting materials were obtained with
>99% purity (Sigma-Aldrich, UK); co-crystal or salt formation
was verified by comparison of X-ray powder diﬀraction (XRPD)
patterns to known structures7,21,28,41–43 or XPS/ssNMR/XRD for
new complexes. The five development complexes were used as
supplied (Sanofi-Aventis, Alnwick) and comprise the dihydro-
chloride salt (1s) and fumaric acid co-crystal (1c) of an API 1,
the difumarate salt 2, and the hydrochloride salts 3 and 4.
Preparation of salts and co-crystals
The non-development co-crystals and salts were prepared by
solid-state-grinding (milling) or solution crystallization. Milling
was performed with a Retsch MM200 mixer mill at a rate of
30 Hz, using two 5 mL stainless steel jars, each containing one
7 mm-diameter stainless steel ball. The complexes were pre-
pared as follows:
(i) 1 : 1 Theophyllinium salicylic-5-sulfonate dihydrate salt
was prepared by both milling and solution crystallization as
described previously.28
(ii) 1 : 1 Theophyllinium salicylic-5-sulfonate monohydrate
salt was prepared by both milling and solution crystallization as
described previously.30
(iii) 2 : 1 Theophylline/oxalic acid co-crystal was prepared by
both milling and solution crystallization as described previously.30
(iv) 1 : 1 Theophylline/maleic acid co-crystal. Anhydrous theo-
phylline (2.023 g, 11.23 mmol) and maleic acid (1.303 g, 1 equiv.)
were dissolved in 35 mL of a 6 : 1 chloroform :methanol solvent
mixture under reflux (53 1C). The solution was removed from
heat and allowed to cool to ambient temperature while stirring.
The resulting precipitate was removed by filtration under
vacuum to give co-crystals with an excess of anhydrous theo-
phylline. The filtrate was then allowed to stand overnight,
Table 1 DpKa values for the seventeen complexes (base/acid), where
DpKa = pKa (base) pKa (acid) based on pKa values.4,12,38–40 For complexes
involving two acids, the pKa of the more basic compound (with more basic
substituent) is taken as pKa (base)
Salt or
co-crystal DpKa
4-Aminobenzoic acid/
4-hydroxy-3-nitrobenzoic acid
C 3.9
Isonicotinamide/4-hydroxy-3-nitrobenzoic acid C 3.0
Theophylline/glutaric acid C 2.6
Theophylline/citric acid C 1.4
Theophylline/malonic acid C 1.1
4-Aminobenzoic acid/3,5-dinitrobenzoic acid C 0.3
Theophylline/maleic acid C 0.2
Theophylline/oxalic acid C 0.3
Fumaric acid co-crystal 1c C 0.3
Isonicotinamide/2,4,6-trihydroxybenzoic acid S 1.8
Theophylline/5-sulfosalicylic acid dihydrate S 2.3
Theophylline/5-sulfosalicylic acid monohydrate S 2.3
3,5-Diaminobenzoic acid/3,5-dinitrobenzoic acid S 2.5
Difumarate salt 2 S 7.2, 4.6
Di-HCl salt 1s S 11.3, 3.3
HCl salt 3 S 15.4
HCl salt 4 S 17.7
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aﬀording the physically pure 1 : 1 co-crystal, which was isolated
by filtration under vacuum. The 1 : 1 co-crystal was also formed
by milling theophylline (109.99 mg, 0.61 mmol) and maleic acid
(70.80 mg, 1 eq.) for 20 minutes.
(v) 1 : 1 Theophylline/malonic acid co-crystal. Milling anhydrous
theophylline (111.70 mg, 0.62 mmol) and malonic acid (64.52 mg,
1 eq.) for 20 minutes formed the 1 : 1 co-crystal. Anhydrous
theophylline (0.5873 g, 3.26 mmol) and malonic acid (0.3392 g,
1.0 equiv.) were also dissolved in 40 mL chloroform and 2 mL
methanol under reflux (55 1C). The solution was removed from
heat and seeded with B45 mg of co-crystal formed by milling.
The solution was allowed to evaporate untilB15 mL remained,
and then filtered under vacuum to give the 1 : 1 co-crystal.
(vi) 1 : 1 Theophylline/citric acid co-crystal was prepared by
milling as described previously.21
(vii) 1 : 1 Theophylline/glutaric acid co-crystal. Milling anhydrous
theophylline (93.7 mg, 0.52 mmol) and glutaric acid (68.7 mg,
1 eq.) for 60 minutes formed the 1 : 1 co-crystal, which was
physically pure as determined by X-ray powder diﬀraction.
Theophylline (0.4972 g, 2.76 mmol) and glutaric acid (0.3646 g,
1 equiv.) were also dissolved in 35 mL chloroform under reflux
(59 1C). The solution was removed from heat and seeded with
B35 mg of co-crystal formed by milling. The solution was
allowed to evaporate until B20 mL volume remained, and the
precipitate (present at the surface) was filtered under vacuum to
give the 1 : 1 co-crystal.
(viii) 1 : 1 3,5-Diaminobenzoic acid/3,5-dinitrobenzoic acid
salt. 3,5-Dinitrobenzoic acid (0.4176 g, 2 mmol) and 3,5-diamino-
benzoic acid (0.3148 g, 2 mmol) were dissolved in 95% ethanol
(25 mL), heated to ensure complete dissolution and left to slowly
cool. Dark brown needle crystals were obtained.
(ix) 1 : 1 4-Aminobenzoic acid/3,5-dinitrobenzoic acid co-crystal.
4-Aminobenzoic acid (0.3477 g, 2.5 mmol) and 3,5-dinitrobenzoic
acid (0.5596 g, 2.6 mmol) were dissolved in methanol (20 mL).
The resulting yellow solution was left to slowly evaporate and
yellow crystals were obtained.
(x) 1 : 1 4-Aminobenzoic acid/4-hydroxy-3-nitrobenzoic acid
co-crystal. 4-Aminobenzoic acid (0.1372 g, 1 mmol) and
Fig. 1 Chemical structures of the individual components (the nitrogen moieties are listed for the development drug substances). The asterisks (*)
indicate the nitrogen atoms sensitive to protonation (Brønsted donation) or intermolecular H-bonding in this study.
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4-hydroxy-3-nitrobenzoic acid (0.1359 g, 0.7 mmol) were mixed
in methanol (1 mL) and heated to 50 1C, and subsequently
cooled to 10 1C at a rate of 0.5 1C min1 using an Avantium
Crystal16.44 Orange-yellow block crystals were obtained.
(xi) 1 : 1 Isonicotinamide/2,4,6-trihydroxybenzoic acid salt.
Isonicotinamide (0.0619 g, 5 mmol) and 2,4,6-trihydroxy-
benzoic acid monohydrate (0.1227 g, 7 mmol) were dissolved
in methanol (7.5 mL). The sample was heated to ensure com-
plete dissolution and left to cool to room temperature. On slow
evaporation, light brown, blocky crystals were produced.
(xii) 1 : 1 Isonicotinamide/4-hydroxy-3-nitrobenzoic acid
co-crystal. Isonicotinamide (0.666 g, 6 mmol) and 4-hydroxy
3-nitrobenzoic acid (0.9309 g, 5 mmol) were dissolved in hot
methanol (35 mL). Upon cooling the solution was left to slowly
evaporate until yellow crystals were obtained.
X-ray diﬀraction (XRD)
Powder XRD patterns were collected using a Rigaku Miniflex
instrument utilizing Cu Ka radiation (l = 1.5406 Å), operating
over 5–401 2y at 1.51min1 with a 0.031 step, 30 kV voltage, and
15mA current. Typically 5 mg of the sample was placed on a small
sample attachment and smoothed to achieve a level surface.
Single crystal XRD data were collected at 100 K using an
Oxford Diﬀraction X-Calibur 2 diﬀractometer utilizing Mo Ka
radiation (l = 0.71073 Å) and an Oxford CryoSystems Cryostream
Controller 700. Data reduction, cell refinement, and multi-scan
absorption corrections were carried out using the program CrysAlis
RED (Oxford Diﬀraction Ltd., version 1.171.32.24, 2008). The
isonicotinamide/4-hydroxybenzoic acid co-crystal structure was
solved with SHELXS-97 and refined on F2 against all reflections
with SHELXL-97.45 The isonicotinamide/2,4,6-trihydroxybenzoic
acid salt structure was solved with SIR9246 and refined on F2
against all reflections using SHELXL-97.45 All non-hydrogen
atoms were refined by direct methods anisotropically; hydrogen
atoms were located in diﬀerence Fourier maps and refined
isotropically, or placed in geometric positions and refined as
riding atoms. CCDC 960081 and 960082.†
X-ray photoelectron spectroscopy (XPS)
XP spectra were recorded using a Kratos Axis Ultra instrument
employing a monochromatic Al Ka source (1486.69 eV), a
hemispherical analyser with a hybrid (electrostatic and mag-
netic) lens system, charge neutralization by filament-generated,
magnetically channeled low-energy electrons, and a delay line
detector (DLD). Samples were fixed using double-sided tape.
Experiments were performed while operating the X-ray source
with a power of 180 W (15 kV and 12 mA), with the pressure
below 108 mbar during analysis. The instrument was operated
in CAE (constant analysis energy) mode, with a pass energy of
20 eV for high resolution scans of the photoemission from
individual core levels, with a calibrated intensity/energy response
and transmission function.36 High resolution spectra were
measured within the spectral range of interest (ca. 20 eV
around the core level emission peaks) with 0.1 eV steps and
300–500 ms dwell time per data point. Repeats were carried out
to check for radiation damage.
Analysis of the data was carried out using Casa XPS software.47
A linear background was used in all curve-fitting (minimizing
w2)47,48 along with a GL(30) lineshape (70% Gaussian, 30%
Lorentzian using the Gaussian/Lorentzian product form).47
For the remainder of this paper, when referring to spectral
contributions of specific atoms in the molecular structure in the
text, the atom of interest will be indicated by being underlined.
Samples naturally containing aliphatic C–C environments were
referenced to adventitious hydrocarbon contamination at
285 eV.48 Samples without C–C environments were referenced
to the lowest EB photoemission; those containing citric acid
were referenced to C–COOH (b-COOH) at 285.2 eV
49 due to the
absence of a clear hydrocarbon shoulder; samples containing
5-sulfosalicylic acid were referenced to CQC at 284.8 eV.
50
Individual chemical environments/functional groups often exhibit
similar ranges of binding energy values where the bonding
or electronegativity is similar, thus where peaks arising from
photoemission from different chemical environments occurred
at the same position or within 0.1 eV, a single peak was used
to represent both environments for clarity and ease of discus-
sion. Repeatability of the peak positions was within 0.1 eV.
Solid-state nuclear magnetic resonance (ssNMR)
Solid-state 15N cross-polarisation magic angle spinning (CP-MAS)
data were acquired using a Bruker DRX500 spectrometer operating
at 50.69 MHz, equipped with a standard bore magnet and a 4 mm
CP-MAS probe. The magic angle adjustment was optimized using
KBr and field homogeneity optimized using adamantane. Data
were collected using a spectral width of 30.3 kHz, 3072 complex
data points, and an acquisition time of 50.8 ms. The relaxation
delay and contact time were optimized for each individual sample.
Sample rotation rates of 5.0–8.0 kHz were employed and typically
greater than 2048 transients acquired. 1H decoupling was achieved
using a TPPM-15 sequence (86.2 kHz). Chemical shifts (dN) were
referenced indirectly with respect to nitromethane, a standard
recommended by IUPAC,51,52 via the high frequency signal of a
traceable standard of ammonium nitrate (dN = 5.1 ppm).
Chemical shifts for the theophylline and API 1 salts and
co-crystals are compared with the values for the free base forms
by the change in chemical shift (Dd = dcomplex  dfree base).
Isotropic chemical shift diﬀerences53 were calculated using
the CASTEP density functional theory (DFT) code,54–56 which
employs the gauge including projector augmented wave (GIPAW)
algorithm. The generalised gradient approximation (GGA) PBE
functional was used with core-valence interactions described by
ultrasoft pseudo-potentials generated on-the-fly. Integrals over
the Brillouin zone were completed using a Monkhorst–Pack grid
with a reciprocal space k-point spacing of 0.04 Å1. A cut-off
energy of 610 eV was defined for kinetic energy of planewaves
used to provide a basis for wavefunctions. For each crystal
structure, full geometry optimization was performed using an
energy cut-off of 300 eV and a k-point spacing of 0.05 Å1, with
fixed lattice parameters. Calculations were performed using
Materials Studio version 4.4, as provided by Accelrys.57 CASTEP
DFT chemical shielding values (s) were obtained for the
nitrogen atoms of the theophylline, 4-aminobenzoic acid,
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3,5-diaminobenzoic acid, and isonicotinamide complexes using
the previously reported7,21,28,41–43 and new isonicotinamide
co-crystal/salt crystal structures as input. Shielding values for
the co-crystal and salts are compared with chemical shifts by
plotting calculated chemical shieldings (s) versus experimental
chemical shifts (dN). A plot of calculated chemical shieldings (s)
versus experimental chemical shifts (dN) for all of the CASTEP
data gives a linear correlation with y = 0.9525x  153.61 (R2 =
0.9893). Predicted chemical shift differences use the free base
as a reference [Ddcalc = (scomplex  sfree base)].
Results and discussion
XPS
The four nitrogen environments (Fig. 1) in the theophylline
complexes result in two X-ray photoemission peak compo-
nents.21,28,30 The peak arising from the C–N/N–CQO nitrogens
occurs at 401.0  0.1 eV for both the co-crystal and salt forms
(Fig. 2, Table 2). In the five theophylline co-crystals, the CQN
photoemission occurs at 399.6  0.1 eV. However, for the
two theophylline salts, this second photoemission peak is at
401.9 eV (Fig. 2b, Table 2), with protonation (CQNH
+) shifting
the CQN peak by +2.3 eV.28,30
The 4-aminobenzoic and 3,5-diaminobenzoic complexes all
have at least one primary amine nitrogen C–NH2 on the base
component and a nitro group NO2 on the acid component
(Fig. 1 and 3). For the 4-aminobenzoic acid/3,5-dinitrobenzoic
acid and 4-aminobenzoic acid/4-hydroxy-3-nitrobenzoic acid
co-crystals (heterodimer bonding) this gives rise to two peaks
at 399.5  0.1 eV and 406.3 eV, from C–NH2 and NO2 respec-
tively (Fig. 3a and b, Table 2).40 When a salt is formed, as in the
case of the 3,5-diaminobenzoic acid/3,5-dinitrobenzoic acid
complex, one of the two amine nitrogens of 3,5-diamino-
benzoic acid is protonated (C–NH3
+), shifting its peak position
to a higher binding energy of 401.9 eV, a shift of +2.4 eV (Fig. 3c,
Table 2).40
There are three diﬀerent types of nitrogen atom in isonicotin-
amide/4-hydroxy-3-nitrobenzoic acid – pyridine CQN and amide
N–CQO of isonicotinamide and nitro NO2 of the acid molecule
(Fig. 1). The nitrogen 1s XPS (Fig. 4a) shows two maxima, with
the high binding energy peak at 406.3 eV arising from the NO2
photoemsission, while the lower energy peak can be fit with two
components at 399.6 and 400.1 eV representing the CQN and
amide N–CQO nitrogen functionalities respectively. With 2,4,6-
trihydroxybenzoic acid, there are no nitrogens in the acid
molecule (no NO2 photoemission), leaving just the CQN and
N–CQO from isonicotinamide. Aside from the isonicotinamide
N–CQO peak at 400.1 eV, the CQN peak is shifted by 2.0 eV
compared to that of isonicotinamide/4-hydroxy-3-nitrobenzoic
acid and is observed at 401.6 eV, representing the change in
chemical state from pyridine CQN to the pyridinium nitrogen
CQNH
+ and evidence of salt formation (Fig. 4b, Table 2).
Subsequent acquisition of the single crystal structure confirms
the XPS-assignment of isonicotinamide/4-hydroxy-3-nitrobenzoic
Fig. 2 N 1s XPS spectra of (a) the theophylline/maleic acid co-crystal and
(b) the theophylline/5-sulfosalicylic acid dihydrate salt (CQNH+, SO3
)28
showing the ratios for types of nitrogen and the corresponding inter-
molecular H-bonding/protonation from the single crystal XRD structures7,28
with the nitrogen sensitive to H-bonding/protonation marked.
Table 2 XPS N 1s peak assignments and positions
Complex (base/acid)
Binding energy/eV
N–SO2 C–N CQN CQN  HO N–CQO C–NH+ CQNH+ NO2
Theophylline/5-sulfosalicylic acid dihydrate salt 401.0 401.0 401.9
Theophylline/5-sulfosalicylic acid monohydrate salt 401.0 401.0 401.9
Theophylline/oxalic acid co-crystal 401.0 399.6 401.0
Theophylline/maleic acid co-crystal 401.1 399.7 401.1
Theophylline/malonic acid co-crystal 401.1 399.7 401.1
Theophylline/citric acid co-crystal 400.9 399.5 400.9
Theophylline/glutaric acid co-crystal 401.0 399.5 401.0
4-Aminobenzoic acid/3,5-dinitrobenzoic acid co-crystal 399.4 406.3
4-Aminobenzoic acid/4-hydroxy-3-nitrobenzoic acid co-crystal 399.6 406.3
3,5-Diaminobenzoic acid/3,5-dinitrobenzoic acid salt 399.5 401.9 406.3
Isonicotinamide/4-hydroxy-3-nitrobenzoic acid co-crystal 399.6 400.1 406.3
Isonicotinamide/2,4,6-trihydroxybenzoic acid salt 400.1 401.6
Di-HCl salt 1s 399.1 399.1 400.3 401.2
Fumaric acid co-crystal 1c 399.2 399.2 399.8 400.6
Difumarate salt 2 399.5 401.7
HCl salt 3 399.6 401.7
HCl salt 4 399.9 401.5
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acid as a co-crystal and isonicotinamide/2,4,6-trihydroxybenzoic
acid as a salt (Fig. 4).
The API 1 provides a variety of nitrogen environments (Fig. 1),
which can be grouped into pyridine derivatives (CQN  3),
amines (C–N  2), and amides (N–CQO  2). For the free
base form (API 1), the photoemission by the C–N and CQN
nitrogens appears around the same binding energy position at
399.1  0.1 eV, while that of N–CQO ranges from 400.3 to
400.6 eV (Fig. 5, Table 2). Differences with respect to the free
base are clearly evident for the salt 1s, with the presence
of a pyridinium CQNH
+ peak component at 401.2 eV shifted
by +2.1 eV compared to unprotonated, pyridine nitrogen (Fig. 5,
Table 2). The relative intensity of this peak is in accord with the
protonation of two of the pyridine nitrogens in the di-HCl salt 1s.
There is also an observable difference for the co-crystal 1c, with a
decrease in the intensity of the C–N/CQN peak relative to the
free base and a broadening between the two free base peak
components. This is accounted for by a third peak at 399.8 eV,
of a relative intensity indicative of one of the C–N/CQN
nitrogens (Fig. 5, Table 2). A shift of +0.6 eV from the C–N/
CQN photoemissions is too small a magnitude for complete
proton transfer, so it appears likely that formation of a new
hydrogen bond results in a high binding energy shift for the
nitrogen acceptor atom.
The difumarate salt 2 has three nitrogen environments
(Fig. 1), comprising two heterocyclic amines (C–N  2) and
one sulfonamide (N–SO2  1). The sulfonamide nitrogen gives
rise to the peak at 399.5 eV, while protonation of the amine
nitrogens results in a peak at 401.7 eV (Fig. 6a, Table 2),
although this API is particularly sensitive to X-ray induced
reduction of NH3
+ to NH2 (occurring at coinciding binding energy
with N–SO2), leading to a departure from the expected 2 : 1 ratio.
58
The HCl salts 3 and 4 have two and three nitrogens respectively
Fig. 3 N 1s XPS spectra of (a) the 4-aminobenzoic acid/3,5-dinitrobenzoic
acid co-crystal, (b) the 4-aminobenzoic acid/4-hydroxy-3-nitrobenzoic acid
co-crystal, and (c) the 3,5-diaminobenzoic acid/3,5-dinitrobenzoic acid salt
(NH3
+, COO), with the corresponding intermolecular H-bonding/protonation
from the single crystal XRD structures.42,43
Fig. 4 N 1s XPS spectra of (a) the isonicotinamide/4-hydroxy-3-nitrobenzoic
acid co-crystal and (b) the isonicotinamide/2,4,6-trihydroxybenzoic acid salt
(NH3
+, COO), with the corresponding intermolecular H-bonding/protonation
from the single crystal XRD structures.
Fig. 5 N 1s XPS spectra of (a) the free base 1, (b) di-HCl salt 1s, and (c)
fumaric acid co-crystal 1c showing the ratios for the types of nitrogen.
Paper PCCP
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
5 
N
ov
em
be
r 2
01
3.
 D
ow
nl
oa
de
d 
on
 0
2/
11
/2
01
6 
15
:3
8:
29
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
1156 | Phys. Chem. Chem. Phys., 2014, 16, 1150--1160 This journal is© the Owner Societies 2014
(Fig. 1), with 3 including an amine (C–N  1) and sulfonamide
(N–SO2  1), while 4 has a heterocyclic amine (C–N  1) and two
amides (N–CQO 2). The sulfonamide peak of 3 and amide peak
of 4 occur at 399.6 and 399.9 eV, respectively, while the protonated
amine C–NH
+ nitrogen photoemissions occur at higher binding
energy, 401.7 and 401.5 eV, respectively (Fig. 6b and c, Table 2).
15N ssNMR
The spectra of the theophylline complexes,21,28,30 1s, and 1c,
were compared with the free base form of each in order to
investigate the changes in chemical shifts occurring with formation
of the complexes. 50–100 ppm shifts relative to the starting compo-
nents (chemical shift difference Dd) are typical for protonation of
aromatic, heterocyclic nitrogen,5,28–31 and shifts of 47–118 ppm
to low frequency confirm salt formation (protonated nitrogen,
CQNH+) for the two theophylline/5-sulfosalicylic acid salts28,30
(Table 3), the isonicotinamide/2,4,6-trihydroxybenzoic acid salt
(Fig. 7, Table 5) and the di-HCl salt 1s (Table 4). The theophylline
salts are protonated at CQN (N9, Fig. 1, Table 3), with ca.50 ppm
shifts (Dd),28,30 and the isonicotinamide salt has a 68.76 ppm
shift on protonation (Fig. 7, Table 5), while di-HCl salt 1s is
protonated in two pyridine positions, N5 and N7, with shifts of
108.0 and 117.8 ppm respectively (Table 4). In contrast, the
fumaric acid co-crystal 1c (Table 4) and the theophylline co-crystal
resonances21,30 (Table 3) show only minor changes in 15N
chemical shifts compared to the base component (Dd), with the
exception of the pyridine N5 resonance in 1c. A shift of 32.6 ppm
to low frequency occurs for N5 of 1c (Table 4), indicating
formation of a strong hydrogen bond that is not present in the
free base form. A component of this change in chemical shift may
be ascribed to conformational/crystallographic packing differ-
ences induced by the hydrogen bonding, which is observed on
comparing different polymorphic forms of the free base.
Aliphatic nitrogen often exhibits much smaller shifts with proto-
nation than its heterocyclic counterparts (e.g. amines vs. pyridines).59
The aliphatic nature of the protonated nitrogen (C–NH3
+) in the
3,5-diaminobenzoic acid/3,5-dinitrobenzoic acid salt results
in a smaller magnitude shift of 14.11 ppm relative to the
unprotonated amine, but this is still sufficient to distinguish
formation of a salt from a co-crystal. There are no significant
shifts indicating protonation of the amine in the 4-aminobenzoic
acid co-crystals (Table 5), confirming they are not salts.
Fig. 6 N 1s photoemission of (a) difumarate salt 2,58 (b) HCl salt 3, and (c)
HCl salt 4 showing the ratios for the types of nitrogen.
Table 3 15N ssNMR chemical shifts for the theophylline co-crystals and salts
Compound
d/ppm
N1 N3 N7 N9
OQC–N–CQO N–CQO C–N CQN
Theophylline 227.04 269.41 218.47 162.74
Dd = d (complex)  d (theophylline)
N1 N3 N7 N9
Complex (base/acid) OQC–N–CQO N–CQO C–N CQN
Theophylline/5-sulfosalicylic
acid dihydrate salt
0.60 1.11 2.44 47.59
Theophylline/5-sulfosalicylic
acid monohydrate salt
1.34 0.41 5.33 50.48
Theophylline/oxalic co-crystal 0.44 1.99 3.79 1.82
Theophylline/maleic co-crystal 0.81 1.96 4.89 5.39
Theophylline/malonic co-crystal 3.85 3.31 6.08 4.07
Theophylline/citric co-crystal 2.32 3.96 8.16 3.72
Theophylline/glutaric co-crystal 2.53 2.95 4.16 1.01
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Density functional theory (DFT) calculations (chemical shielding
values, s) were performed for the nitrogens of the theophylline,
aminobenzoic, and isonicotinamide complexes in order to
compare with experimental data (chemical shifts, d). The
plot of s versus d (Fig. 8) shows a linear correlation with
y = 0.9525x  153.61 (R2 = 0.9893). This demonstrates the
robustness of using CASTEP for relating 15N ssNMR chemical
shifts to molecular structure and, therefore, providing NMR
based evidence for proof of co-crystal or salt formation.
The predicted chemical shift diﬀerences can be related to
the H-bond length, giving a measure of H-bond strength, and
providing an example of how NMR crystallography can be used
in a complementary way with respect to X-ray crystallography.60
For example, the predicted values as a function of distance
between N of the base and H of the acid component show a
clear separation between unprotonated (co-crystals, dZ 1.53 Å)
and protonated nitrogen (salts, dr 1.11 Å) for the theophylline
complexes (Fig. 9). Additional multi-dimensional solid-state
NMR studies are in progress to further characterize the nature
of the hydrogen bonding in these co-crystals and salts.
DpKa correlations
Plotting the nitrogen XPS and ssNMR values for the co-crystals
and salts against DpKa (Fig. 10) shows the dependence of the
extent of proton transfer on the strength of the acidic compo-
nent. Of the 17 complexes, the co-crystals have DpKar 0.3, and
the salts have DpKaZ 1.8, with DpKa ranging from 3.9 to 17.7,
and four salts and two co-crystals have been assigned that are
within the range for DpKa typically viewed as the transition
region (0–3) for which formation of a salt vs. co-crystal is not
predictable.12 Recently, pKa matching has been used as a tool
for predicting H-bond strengths61 (including the proposed pKa
Fig. 7 15N ssNMR spectra of (a) the isonicotinamide/4-hydroxy-3-nitrobenzoic
acid co-crystal and (b) the isonicotinamide/2,4,6-trihydroxybenzoic acid salt,
showing the shift with proton transfer.
Table 4 15N ssNMR chemical shifts for the salt (1s) and co-crystal (1c) of API 1
Compound
d/ppm
N1 amine N2 amide N3 amine N4 amide N5 pyridine N6 pyridine N7 pyridine
Free base (API 1) 298.04 275.91 249.82 240.45 93.20 117.03 70.04
Dd = d (complex)  d (free base)
Complex (base/acid) N1 amine N2 amide N3 amine N4 amide N5 pyridine N6 pyridine N7 pyridine
Free base form I 0.91 2.31 0.58 1.93 13.95 2.49 4.30
Fumaric acid
co-crystal 1c
9.57 2.96 3.83 2.14 32.60 2.82 1.12
Di-HCl salt 1s 15.83 0.37 4.21 2.24 108.02 3.13 117.79
Table 5 15N ssNMR chemical shifts for the aminobenzoic and isonicotinamide co-crystals and salts
Complex (base/acid)
d/ppm
CQN C–N N–CQO CQNH
+ C–NH
+
NO2
4-Aminobenzoic acid/3,5-dinitrobenzoic acid co-crystal 311.04 16.28
4-Aminobenzoic acid/4-hydroxy-3-nitrobenzoic acid co-crystal 318.15 8.64
3,5-Diaminobenzoic acid/3,5-dinitrobenzoic acid salt 314.94 329.05 14.13
18.53
Isonicotinamide/4-hydroxy-3-nitrobenzoic acid co-crystal 97.87 275.69 11.61
Isonicotinamide/2,4,6-trihydroxybenzoic acid salt 275.31 166.63
Fig. 8 CASTEP DFT nitrogen chemical shieldings (s) vs. experimental 15N
ssNMR chemical shifts (d).
Paper PCCP
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
5 
N
ov
em
be
r 2
01
3.
 D
ow
nl
oa
de
d 
on
 0
2/
11
/2
01
6 
15
:3
8:
29
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
1158 | Phys. Chem. Chem. Phys., 2014, 16, 1150--1160 This journal is© the Owner Societies 2014
slide rule62). A correlation between bond lengths in crystals and
DpKa values was shown for N–H  O/O–H  N bonds.62 In line
with this work, we find a clear separation between N 1s XPS
chemical shifts of the co-crystals around 399.6 eV and salts
around 401.7 eV (Fig. 10). Measurement of the N 1s binding
energy unambiguously determines whether protonation has
occurred, with a mean N 1s binding energy difference of +2.1 eV
for N- NH+.
As the 15N ssNMR chemical shift d varies significantly with
each base moiety and thus the absolute value is not a unique
identifier for protonation state, the chemical shift diﬀerence
(Dd, Fig. 10) is used to compare against the DpKa for the
complexes (no ssNMR data for API 2, 3, and 4). There is a
clustering of Dd values for the co-crystals, although there is an
overlap between co-crystals and salts. The smallest chemical
shift observed for protonation of nitrogen (14.11 ppm) and salt
formation occurs for 3,5-diaminobenzoic acid/3,5-dinitrobenzoic
acid and is a result of the reduced magnitude of the shift
for aliphatic rather than heterocyclic aromatic nitrogen59 as
mentioned previously, and the theophylline and isonicotin-
amide salts exhibit Dd of 50 to 70 ppm while the di-salt
API 1s shows larger magnitude shifts of around 110 ppm. The
largest (most negative) shift for nitrogen within the co-crystals
occurs for the development drug co-crystal 1c, causing it to be
greater than that of the signal from the aliphatic salt – for-
mation of a strong hydrogen bond that is not present in the free
base form (API 1) is intimated for co-crystal 1c, influencing the
chemical shift, as well as a possible contribution from con-
formational/crystallographic packing differences. Comparing
shifts between compounds sharing a component (such as salts
and co-crystals which share the same free base) rather than
the whole series clearly identifies each form correctly (Fig. 7,
Tables 3–5).
XPS core level chemical shifts reflect primarily the influence
of the most immediate atomic neighbours on the electronic
state of the photoexcited atom,33,48,50,63 with the eﬀect of strong
local intermolecular interactions such as ionic and H-bonding
dominating over the comparatively weaker van-der-Waals and
dipole interactions. It is for this reason that the core level
binding energies reported in Table 2 and Fig. 10 are so
universally sensitive to local structure and thus protonation
state. In contrast, NMR is far more dependent on the extended
environment and interactions, which leads to greater variance
in Dd as an indicator of protonation, although it does provide
spatial resolution (allowing structurally inequivalent atoms of
the same type of functional group to be distinguished). The
combination of XPS and ssNMR to identify when hydrogen
transfer has occurred from acid to base component is therefore
especially strong, making assignment of salt or co-crystal
unambiguous.
Conclusions
Nitrogen XPS and ssNMR chemical shifts clearly separate pro-
tonated from unprotonated nitrogen for a wide range of diﬀerent
solid-state donor–acceptor systems, including five pharmaceutical
drug substances. The nature of the intermolecular interaction
between the acid–base components was correctly identified for
the eight salts and nine co-crystals. Brønsted proton transfer
to nitrogen of the base component (salt formation) leads to
chemical shifts towards higher core level binding energies in
XPS and to lower frequency in ssNMR, while the hydrogen-
bonded co-crystals exhibited only minor shifts compared to the
free base form, with the exception of one of the pharmaceutical
co-crystals (1c). The salt and co-crystal of the same API (1)
Fig. 10 Correlations between N 1s XPS and 15N ssNMR chemical shifts
with DpKa, illustrating the clear separation between protonated (salt) and
unprotonated nitrogen (co-crystal) with XPS and the overlap for new
H-bond formation in a co-crystal (1c) and protonation of aliphatic nitrogen
in a salt (3,5-diamino/3,5-dinitro) with ssNMR.
Fig. 9 CASTEP DFT optimised H-bond lengths versus predicted chemical
shift diﬀerences (Dd).
PCCP Paper
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
5 
N
ov
em
be
r 2
01
3.
 D
ow
nl
oa
de
d 
on
 0
2/
11
/2
01
6 
15
:3
8:
29
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
This journal is© the Owner Societies 2014 Phys. Chem. Chem. Phys., 2014, 16, 1150--1160 | 1159
allowed comparison between the magnitude of the shift for
formation of a strong hydrogen bond (at a position where there
was none in the free base) compared to that for complete
hydrogen transfer (protonation) at the same position in the
salt. DFT-calculated 15N ssNMR results show good correlation
with experimental data, allowing prediction of chemical shifts
and assignment of salt or co-crystal, and the strong influence of
H-bond strength on the chemical shift.
Our data demonstrate both the versatility and unambiguity
of such a combined XPS/ssNMR approach, which has, to our
knowledge, never been systematically pursued before across
such a large body of samples. The results will inform a more
critical assessment of the possibilities and limitations asso-
ciated with XPS and ssNMR, and provide a reference database
for future investigations of hydrogen-bonding and protonation
in other systems, for example the study of solvation eﬀects in
the nucleation and growth of organic crystals.64
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